Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a consumer health company focused on everyday health products, covers the month of April 2026. The report specifically details transactions in the company's own shares conducted under a share buyback programme announced on March 12, 2026.
Key Financial Metrics and Share Transactions
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on share repurchase activity.
- Total Shares Purchased: 7,740,513 ordinary shares for cancellation.
- Transaction Period: April 7, 2026, to April 10, 2026.
- Trading Venues: London Stock Exchange (CBOE UK/BXE, CBOE UK/CXE) and Aquis.
- Price Range: Highest price paid was 376.10 pence per share; lowest price paid was 361.60 pence per share.
- Post-Transaction Capital: Registered share capital stands at 8,919,824,040 ordinary shares of £0.01 each.
- Treasury Shares: 12,439,998 shares held as treasury shares.
- Voting Rights: 8,907,384,042 ordinary shares with voting rights.
Material Changes
The primary material change reported is the reduction of outstanding shares due to the cancellation of 7,740,513 shares purchased during the first week of April 2026. This action reduces the total number of shares with voting rights.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, management commentary on operational performance, or discussion of risks and contingencies. It is a regulatory disclosure of share transactions required under the Market Abuse Regulation (Regulation (EU) No 596/2014).
Key Facts for Investor Verification
- Verify the total cost of the buyback by calculating the volume-weighted average price against the total shares purchased.
- Confirm the updated number of voting shares (8,907,384,042) for disclosure threshold calculations under FCA rules.
- Review the full breakdown of individual trades available via the provided London Stock Exchange link for granular execution data.
- Note that this filing does not contain financial performance data; refer to the most recent Form 20-F or quarterly reports for revenue and earnings.